Doximity Sees Unusually High Options Volume (NYSE:DOCS)

Posted by George Bondi on Aug 3rd, 2026

Doximity, Inc. (NYSE:DOCS – Get Free Report) was the target of some unusual options trading activity on Monday. Investors bought 7,339 call options on the stock. This represents an increase of 216% compared to the typical volume of 2,319 call options.

Doximity Price Performance

Shares of NYSE:DOCS traded up $0.64 during mid-day trading on Monday, hitting $21.55. The company had a trading volume of 360,771 shares, compared to its average volume of 3,666,417. Doximity has a one year low of $17.15 and a one year high of $76.51. The firm has a fifty day moving average price of $21.06 and a 200 day moving average price of $24.90. The company has a market capitalization of $3.94 billion, a PE ratio of 21.78, a price-to-earnings-growth ratio of 7.59 and a beta of 1.29.

Analysts Set New Price Targets

Several research firms recently commented on DOCS. Robert W. Baird reiterated a “neutral” rating and set a $18.00 target price (down from $40.00) on shares of Doximity in a research report on Thursday, May 14th. Wells Fargo & Company reaffirmed an “equal weight” rating and set a $18.00 price target (down from $32.00) on shares of Doximity in a research report on Thursday, May 14th. BTIG Research downgraded Doximity from a “buy” rating to a “neutral” rating in a report on Thursday, May 14th. Weiss Ratings lowered Doximity from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Friday, May 15th. Finally, Barclays reissued an “equal weight” rating and issued a $20.00 price objective (down from $38.00) on shares of Doximity in a research note on Thursday, May 14th. Two analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating, thirteen have given a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $29.33.

Read Our Latest Stock Analysis on DOCS

Insiders Place Their Bets

In related news, insider Siddharth Sitaram sold 2,444 shares of the company’s stock in a transaction on Monday, June 8th. The stock was sold at an average price of $20.41, for a total transaction of $49,882.04. Following the completion of the sale, the insider directly owned 90,706 shares in the company, valued at $1,851,309.46. This represents a 2.62% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Kira Scherer Wampler sold 9,000 shares of the stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $26.06, for a total transaction of $234,540.00. Following the completion of the transaction, the director directly owned 19,839 shares of the company’s stock, valued at $517,004.34. This trade represents a 31.21% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 13,753 shares of company stock valued at $343,925 in the last three months. 31.80% of the stock is owned by insiders.

Institutional Investors Weigh In On Doximity

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. raised its stake in Doximity by 4.1% during the 4th quarter. Vanguard Group Inc. now owns 13,285,485 shares of the company’s stock worth $588,281,000 after buying an additional 518,916 shares during the period. UBS Group AG grew its stake in Doximity by 26.5% in the fourth quarter. UBS Group AG now owns 680,260 shares of the company’s stock valued at $30,122,000 after acquiring an additional 142,408 shares during the period. Northwestern Mutual Wealth Management Co. increased its holdings in shares of Doximity by 325,436.6% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 1,298,891 shares of the company’s stock valued at $57,515,000 after acquiring an additional 1,298,492 shares in the last quarter. Rhenman & Partners Asset Management AB increased its holdings in shares of Doximity by 174.1% during the fourth quarter. Rhenman & Partners Asset Management AB now owns 372,750 shares of the company’s stock valued at $16,505,000 after acquiring an additional 236,750 shares in the last quarter. Finally, Harel Insurance Investments & Financial Services Ltd. raised its position in shares of Doximity by 108.5% during the fourth quarter. Harel Insurance Investments & Financial Services Ltd. now owns 173,621 shares of the company’s stock worth $7,688,000 after purchasing an additional 90,341 shares during the period. 87.19% of the stock is owned by institutional investors.

Doximity Company Profile

(Get Free Report)

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.